Understanding the diverse mechanisms by which EZH2 contributes to lymphoma pathogenesis, including epigenetic regulation and interactions with the tumor microenvironment, provides valuable insights for targeting EZH2 in lymphoma treatment (28, 29). This evidence concerns the gene EZH2 and lymphoma.